FILTER

Refine your search with the following facets to narrow down your results.

15 Current news of Midatech

Positive Results in Proof-of-Concept Study with Sustained Release Treatment for Uveitis

23-Feb-2015 - Midatech Pharma announced positive results from a proof-of-concept in vivo study with OpsiSporin, a sustained release treatment for uveitis. Uveitis is an inflammatory process affecting the iris, the ciliary body, the choroid layer or all or part of these structures of the eye. Whilst treatments ...

microencapsulation uveitis

Midatech Pharma Wins Innovation & Excellence in Healthcare Award

11-Feb-2015 - Midatech Pharma announced that it has won the Healthcare Award in the 2015 Corporate LiveWire Innovation & Excellence awards.The Innovation & Excellence Awards is an international business awards programme organised by Corporate LiveWire to celebrate excellence amongst individual entrepreneurs, ...

Midatech Pharma awarded EU grant funding to research into glycan based multivalent immunotherapeutics

22-Dec-2014 - Midatech Pharma announced that a consortium of academic and industry groups including Midatech has been awarded a €3.8 million European Union grant.The grant will fund a project entitled “IMMUNOSHAPE” which aims to train a new generation of scientists capable of applying state of the art ...

glycans grants immunotherapeutics

Midatech and MonoSol Rx Announce Positive Phase 1 Clinical Results for their Novel Transbuccal Oral Insulin Film Product

07-May-2012 - Midatech Ltd. and MonoSol Rx LLC announced positive bioavailability and pharmacokinetic results from a first-in-human Phase 1 clinical study of their Midaform™ Insulin PharmFilm product in 27 healthy volunteers. The companies have licensed to their joint venture company, MidaSol Therapeutics LLC, ...

diabetes insulin

Midatech Secures £6.3 Million Financing to Strengthen Product Development Portfolio

09-Jan-2012 - Midatech Ltd. announced it has raised £6.3 million through a private investment round.This financing will be used to strengthen and diversify Midatech’s product development portfolio, especially in oncology. It will be used to support clinical development of chemotherapeutic gold nanoparticles ...

Midatech receives Regulatory Approval for Clinically Testing Ultra-small Gold Nanoparticles

17-Nov-2011 - Midatech Ltd. announced it has received Swissmedic approval to start the First-in-Human clinical trial with insulin-coated gold nanoparticles, which will be coordinated through its Swiss subsidiary PharMida AG. The trial is designed to assess the safety profile of insulin-coated gold ...

clinical trials gold nanoparticles nanoparticles

Midatech Receives Manufacturing License in Spain for its Nanoparticles

06-Jun-2011 - Midatech Biogune S. L., the nanoparticle manufacturing subsidiary of the Midatech Group, announced that it has been granted an Investigational Medicinal Products (IMP) License from the Spanish Medicines Agency for the cGMP manufacture of clinical grade nanoparticles at its state-of-the art ...

Investigational Medicinal Products (IMP) License nanoparticles

MonoSol Rx and Midatech Ltd Complete Transbuccal Insulin Delivery Study in Primate Diabetes Model

11-Jan-2011 - MonoSol Rx and Midatech Group Ltd. announced positive results from a pre-clinical study of insulin PharmFilm, the first-ever oral insulin film formulation to transbuccally deliver an active therapeutic dose of insulin in a diet-induced diabetic primate model.The two companies are developing ...

insulin

Midatech and Monosol Rx Announce Filing of Joint Patent Application for Nanoparticle Film Delivery Systems

18-Aug-2010 - Midatech Group Ltd. and MonoSol Rx announced the filing of a provisional US patent application for “Nanoparticle Film Delivery Systems.” The applications submitted to the United States Patent and Trademark Office (USPTO) relate to therapeutic uses of nanoparticle-based proteins and peptides ...

biologics drug delivery glucose +3

Midatech and Immunotope Form Joint Venture, Syntara LLC, for the Development of Immune Therapies

14-Jul-2010 - Midatech Group Ltd. and Immunotope Inc announced the formation of a joint venture Syntara LLC, to develop antigen based products for immune therapies to treat chronic viral infections and certain cancers. Commenting on the formation of the joint venture, Professor Tom Rademacher, Chairman of ...

joint ventures validation viral infection